Early Use in Psychotherapy
The History of MDMA June 29, 2023 Peer reviewed DOI: 10.1093/oso/9780198867364.003.0006
Summary
MDMA was used in psychotherapy starting in 1977 by some psychiatrists and psychotherapists who found it helpful for suppressing fear responses, allowing patients to process painful memories. It also facilitated communication in couple therapy. The initial research involved a few hundred patients and showed some success. As concerns about MDMA's scheduling arose, therapists organized a conference on its therapeutic use and conducted a study to demonstrate its safety.
Study at a glance
| Sample size | 300 |
|---|---|
| Population | patients undergoing psychotherapy with MDMA |
| Key finding | MDMA was found to be an effective aid in psychotherapy by suppressing fear responses and facilitating communication. |
Abstract
Abstract From 1977, MDMA was used in psychotherapy by a handful of psychiatrists and psychotherapists. They found it to be an ideal aid to psychotherapy as it does not affect ego-functions to the same extent as other psychedelic drugs. Its main effect seemed to be suppression of the fear response, allowing patients the opportunity to observe and reprocess painful memories. Another application was found in couple therapy, as it enables couples to communicate without their usual anxiety-driven limitations. At first, the therapists were eager to keep the substance secret, being afraid it might, as a psychotherapeutic drug, end up having the same fate as LSD. However, their research into its psychotherapeutic utility was broad-based and covered a few hundred patients, apparently with some success. The chapter describes the initial history of the therapeutic use of MDMA, and the people and organizations involved with it. To illustrate its early therapeutic use, five therapists and their work are described in more detail. When the therapists became aware that MDMA might be scheduled, they organized a small conference on its therapeutic use and a psychophysiological study to show its physiological safety. A description of the fate of the research protocols submitted to the Food and Drug Administration (FDA) after its scheduling completes the picture.